Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis.

@article{Aune2011IncreasedCH,
  title={Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis.},
  author={Guro Aune and Aina-Mari Lian and Solveig Tingulstad and Sverre H. Torp and Siri Forsmo and Janne E Reseland and Astrid Kamilla Stunes and Unni Syversen},
  journal={Gynecologic oncology},
  year={2011},
  volume={121 2},
  pages={402-6}
}
OBJECTIVE Hepatocyte growth factor (HGF) has been described to be increased in different cancers. In the present study we wanted to investigate whether HGF in serum can distinguish between benign and malignant ovarian tumors, and whether serum HGF levels can predict the outcome in patients with ovarian carcinomas. METHODS We included 123 consecutive patients appointed for laparotomy due to a pelvic mass. Preoperative levels of serum cancer antigen 125 (CA 125), HGF and HGF activator (HGFA… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy

  • T Mizuguchi
  • J Gastrointest Surg
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…